Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial. [electronic resource]
Producer: 20200928Description: 1217-1225 p. digitalISSN:- 1572-0241
- Adult
- Antiviral Agents -- administration & dosage
- Bone Density
- Double-Blind Method
- Drug Administration Schedule
- Female
- Guanine -- administration & dosage
- Hepatitis B virus
- Hepatitis B, Chronic -- blood
- Humans
- Male
- Middle Aged
- Organophosphonates -- administration & dosage
- Republic of Korea
- Tenofovir -- administration & dosage
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.